Target type: biologicalprocess
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus. [GOC:mah]
Cellular response to mercury ion is a complex process involving a cascade of events that ultimately aim to mitigate the toxic effects of mercury. Mercury, in its various forms, can readily penetrate cell membranes and interfere with a wide range of cellular processes. The initial encounter with mercury ions triggers a stress response within the cell. This response involves the activation of various signaling pathways, including the oxidative stress response, the unfolded protein response (UPR), and the inflammatory response. Oxidative stress occurs as mercury ions interact with cellular components, generating reactive oxygen species (ROS). These ROS can damage DNA, proteins, and lipids, leading to cellular dysfunction. The UPR is activated in response to the accumulation of misfolded proteins, which is a consequence of mercury's interference with protein folding machinery. The inflammatory response is triggered by the release of pro-inflammatory cytokines, contributing to further cellular damage. To counteract these detrimental effects, cells employ a variety of defense mechanisms. These include the upregulation of antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase, to neutralize ROS. Furthermore, cells activate detoxification pathways to bind and remove mercury ions. These pathways involve the expression of specific proteins, such as metallothioneins, which can bind to mercury ions and sequester them. Additionally, cells may activate processes like autophagy to eliminate damaged organelles and proteins. If the cellular response is insufficient or overwhelmed by excessive mercury exposure, the cell may undergo apoptosis (programmed cell death) or necrosis. The ultimate outcome of cellular response to mercury ion depends on the concentration of mercury, the duration of exposure, and the cell's ability to mount an effective defense. The disruption of these cellular processes can have significant consequences, potentially leading to various pathologies including neurotoxicity, nephrotoxicity, and developmental disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Excitatory amino acid transporter 3 | An excitatory amino acid transporter 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43005] | Homo sapiens (human) |
Aquaporin-1 | An aquaporin-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P29972] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | non-proteinogenic alpha-amino acid | |
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
aspartic acid | aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. L-aspartic acid : The L-enantiomer of aspartic acid. | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
sym 2081 | |||
dihydrokainate | dicarboxylic acid | ||
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
hinokinin | hinokinin : A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer). hinokinin: suppresses expression of both HBsAg and HBeAg | benzodioxoles; gamma-lactone; lignan | trypanocidal drug |
3-hydroxyaspartic acid, (threo-l)-isomer | (3S)-3-hydroxy-L-aspartic acid : The (3S)-diastereomer of 3-hydroxy-L-aspartic acid. | 3-hydroxy-L-aspartic acid | metabolite |
2-amino-3-phenylmethoxybutanedioic acid | aspartic acid derivative | ||
dl-threo-beta-benzyloxyaspartate | |||
cgp 71683 a | naphthalenes; sulfonic acid derivative | ||
l-beta-threo-benzyl-aspartate | L-beta-threo-benzyl-aspartate: structure in first source | ||
ucph 101 | 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile: structure in first source |